Arexvy: Canada approves GSK’s RSV vaccine
GSK has received Canadian approval for Arexvy, its respiratory syncytial virus vaccine in adults between… Read More
2 months ago
GSK has received Canadian approval for Arexvy, its respiratory syncytial virus vaccine in adults between… Read More